In a report released yesterday, George Sutton from Craig-Hallum maintained a Buy rating on Core Scientific Inc (CORZ – Research Report). The ...

Craig-Hallum analyst Chase Knickerbocker lowered the firm’s price target on Phathom Pharmaceuticals (PHAT) to $19 from $27 and keeps a Buy ...

Fintel reports that on February 28, 2025, Craig-Hallum initiated coverage of MediWound (NasdaqGM:MDWD) with a Buy ...

Fintel reports that on February 12, 2025, Craig-Hallum initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Buy recommendation. Analyst Price Forecast Suggests 57.19% Upside As of January 29, ...

https://www.tipranks.com/news/the-fly/doubleverify-price-target-lowered-to-24-from-28-at-bmo-capital As previously reported, Craig-Hallum downgraded Akamai (AKAM) to ...

As previously reported, Craig-Hallum analyst Albert Lowe initiated coverage of Eupraxia Pharmaceuticals (EPRX) with a Buy ...

Airgain (NASDAQ:AIRG – Free Report) had its price objective reduced by Craig Hallum from $12.00 to $9.00 in a research report report published on Friday morning,Benzinga reports. Craig Hallum ...

Arlo Technologies (NYSE:ARLO – Get Free Report) had its price target lifted by investment analysts at Craig Hallum from ...

As of February 19, 2025, the average one-year price target for MediWound is $29.58/share. The forecasts range from a low of $25.25 to a high of $37.80. The average price target represents an ...

Fintel reports that on February 12, 2025, Craig-Hallum initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Buy recommendation. As of January 29, 2025, the average one-year price target ...